Home › Funds › PSP Research LLC › NTLA

PSP Research LLC position in NTLA

INTELLIA THERAPEUTICS INC · Health Care

PSP Research LLC reported holding 20,000 shares of NTLA (INTELLIA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$241K, representing 0.17% of its reported portfolio and ranking #25 among its reported holdings. PSP Research LLC has disclosed NTLA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)20.00K sh
Reported value held$241.20K
Portfolio Weight0.17%
First reportedQ1 2026
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's NTLA position evolved

PSP Research LLC first disclosed a stake in NTLA in Q1 2026 at 26,900 shares (US$345K). Across 3 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 20,000 shares valued at US$241K. Notable position changes include a 26% trim in Q2 2026 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 26.90K $344.86K New
Q2 2026 20.00K $338.40K Reduce
Q3 2026 20.00K $241.20K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NTLA and 13F data

NTLA (INTELLIA THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in NTLA — the largest reported positions include ARK Invest (US$285.5M), RA CAPITAL MANAGEMENT, L.P. (US$76.6M), REGENERON PHARMACEUTICALS, INC. (US$62.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NTLA

All NTLA fund holders →

FAQ

How long has PSP Research LLC held NTLA?

PSP Research LLC has disclosed NTLA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is PSP Research LLC's current position in NTLA?

As of Q3 2026, PSP Research LLC holds 20.00K shares of NTLA (INTELLIA THERAPEUTICS INC), valued at $241.20K, representing 0.17% of its reported portfolio and ranking #25.

Has PSP Research LLC been buying or selling NTLA?

In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in NTLA.

Which other funds hold NTLA?

Other major institutional holders of NTLA include ARK Invest, RA CAPITAL MANAGEMENT, L.P., REGENERON PHARMACEUTICALS, INC., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.